January 18, 2016
No known treatment has showed significant long-term remission that is strong enough to declare a Lupus patient as cured. That was, until now.
Today, biotech experts at the French medical research company, Neovacs, are on the brink of a true landmark medical breakthrough. At Neovacs, the focus is not on drug treatment; instead, Neovacs believes in the therapeutic philosophy of the body’s own immunity. (In other words, enhancing the immunity of the patient to develop an adequate response to fight disease.) It is currently in the advanced clinical trial stage of a therapeutic injectable vaccine for Lupus whose clinical trial results have been nothing short of astounding: complete remission of symptoms for years, no side effects, no secondary treatments needed, and best of all, a remarkably strong immune system.
Watch The Balancing Act and see why experts are saying a cure for Lupus is, quite iterally, imminent.
Because Lucara gives back 55% of the revenue it earns from diamonds to the people of Botswana, every child in Botswana receives a free education.
Lucara Diamond emphasizes a healthy and safe work environment and creating a positive economic and social impact on local communities where they operate.
Natural diamonds are among the hardest and most ancient substances on earth—some specimens were formed three billion years ago.